Alpha-1 antitrypsin deficiency is a genetic, inherited metabolic condition present from the exact moment of conception, meaning the underlying DNA or RNA mutations exist throughout a person's life. However, clinical symptoms and physiological manifestations rarely appear during early childhood, typically becoming clinically apparent during early adulthood or middle age—most commonly between the ages of twenty and fifty. The precise age of onset and severity of clinical complications, such as progressive pulmonary emphysema or liver dysfunction, vary significantly among individuals depending on environmental factors like cigarette smoke exposure, occupational dust inhalation, lifestyle habits, and specific inherited genetic allele combinations.